Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.

por Jessica H Brehm, Yanille Scott, Dianna L Koontz, Steven Perry, Scott Hammer, David Katzenstein, John W Mellors, Nicolas Sluis-Cremer, AIDS Clinical Trials Group Study 175 Protocol Team
Publicado em 2012-01-01